{"id":51136,"date":"2022-11-22T16:02:37","date_gmt":"2022-11-22T15:02:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/"},"modified":"2022-11-22T16:02:37","modified_gmt":"2022-11-22T15:02:37","slug":"choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/","title":{"rendered":"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System"},"content":{"rendered":"<div>\n<p>KNOXVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of an additional lordotic offering for their stand-alone anterior lumbar interbody \u2013 Harrier SA.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/5\/harrier_stg_cover_splash.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645242\/5\/Choice_logo_NEW.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645242\/21\/Choice_logo_NEW.jpg\"><\/a><\/p>\n<p>\nHarrier SA is a 3D printed stand-alone screw-based system incorporating ChoiceSpine&#8217;s proprietary BioBond\u2122 porous structure technology. The system has had great success since launching in May of 2021. ChoiceSpine is pleased to announce the addition of the 20\u00b0 lordotic offering in accompanying the current 10\u00b0 and 15\u00b0 lordotic options. The Harrier SA System now provides further flexibility to the surgeon community to address different patient anatomies.\n<\/p>\n<p>\nKeith Clements, Vice President of Sales, states, &#8221; The addition of a hyperlordotic option for stand-alone ALIF procedures delivers on ChoiceSpine\u2019s commitment to providing innovative products as the company aims to improve people\u2019s lives with a positive customer experience.\u201d\n<\/p>\n<p>\nThe Harrier SA Anterior Lumbar Interbody System includes:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nBiobond\u2122 3D printed titanium porous structure\n<\/li>\n<li>\nThree Lordotic options for each footprint: 10\u00b0, 15\u00b0, and 20\u00b0<br \/>\n<br \/><i>(20\u00b0 requires supplemental fixation)<\/i>\n<\/li>\n<li>\nIntegrated Cam-Locking mechanism\n<\/li>\n<li>\nLarge graft window perfect for combining with Stratofuse<sup>\u00ae<\/sup> Biologics\n<\/li>\n<li>\nCorticocancellous lag screws\n<\/li>\n<li>\nSeamless instrumentation\n<\/li>\n<\/ul>\n<p>\nChoiceSpine LLC is a spinal device company located in Knoxville, TN, privately held by Altus Capital Partners. ChoiceSpine prides itself on providing excellent products aimed at improving people&#8217;s lives through a positive customer experience. Here at ChoiceSpine, we offer a variety of surgeon-focused product lines that are designed to be safe, efficient, and easy to use. By focusing on a collaborative team approach with physicians and industry partners, ChoiceSpine continues to deliver upon product commitments, maintain cutting-edge research and development, and bring technically superior products to the forefront of the spinal implant industry. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.choicespine.com&amp;esheet=52976467&amp;newsitemid=20221122005584&amp;lan=en-US&amp;anchor=www.choicespine.com&amp;index=1&amp;md5=b115e01073f496680c6e9832573a5600\" rel=\"nofollow noopener\" shape=\"rect\">www.choicespine.com<\/a>.\n<\/p>\n<p>\nAltus Capital Partners is a private equity firm that makes control investments in middle-market manufacturing businesses. We believe that our exclusive focus on manufacturing give us a unique understanding of the opportunities and challenges companies face in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. With offices in Wilton, CT, and Lincolnshire, IL, Altus Capital Partners has completed 18 platform investments and numerous add-on acquisitions since 2003. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.altuscapitalpartners.com&amp;esheet=52976467&amp;newsitemid=20221122005584&amp;lan=en-US&amp;anchor=www.altuscapitalpartners.com&amp;index=2&amp;md5=e42d017a05b1e7274a2b59f157cd905f\" rel=\"nofollow noopener\" shape=\"rect\">www.altuscapitalpartners.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nRon Moore<br \/>\n<br \/>Sr. Director of Marketing<br \/>\n<br \/>865-246-3333<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#114;&#109;&#111;&#111;&#x72;&#x65;&#x40;&#x63;&#x68;&#x6f;&#x69;&#x63;&#x65;spin&#101;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">rm&#111;&#111;&#114;&#x65;&#x40;&#x63;&#x68;oi&#99;&#101;&#115;&#x70;&#x69;&#x6e;&#x65;&#46;c&#111;&#109;<\/a><br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.choicespine.com&amp;esheet=52976467&amp;newsitemid=20221122005584&amp;lan=en-US&amp;anchor=choicespine.com&amp;index=3&amp;md5=33a83c8e435254241fe339e8975d6a1f\" rel=\"nofollow noopener\" shape=\"rect\">choicespine.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>KNOXVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of an additional lordotic offering for their stand-alone anterior lumbar interbody \u2013 Harrier SA. Harrier SA is a 3D printed stand-alone screw-based system incorporating ChoiceSpine&#8217;s proprietary BioBond\u2122 porous structure technology. The system has had great success since launching in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51136","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"KNOXVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of an additional lordotic offering for their stand-alone anterior lumbar interbody \u2013 Harrier SA. Harrier SA is a 3D printed stand-alone screw-based system incorporating ChoiceSpine&#8217;s proprietary BioBond\u2122 porous structure technology. The system has had great success since launching in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T15:02:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System\",\"datePublished\":\"2022-11-22T15:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005584\\\/en\\\/1645257\\\/21\\\/harrier_stg_cover_splash.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/\",\"name\":\"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005584\\\/en\\\/1645257\\\/21\\\/harrier_stg_cover_splash.jpg\",\"datePublished\":\"2022-11-22T15:02:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005584\\\/en\\\/1645257\\\/21\\\/harrier_stg_cover_splash.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005584\\\/en\\\/1645257\\\/21\\\/harrier_stg_cover_splash.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/","og_locale":"en_US","og_type":"article","og_title":"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System - Pharma Trend","og_description":"KNOXVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of an additional lordotic offering for their stand-alone anterior lumbar interbody \u2013 Harrier SA. Harrier SA is a 3D printed stand-alone screw-based system incorporating ChoiceSpine&#8217;s proprietary BioBond\u2122 porous structure technology. The system has had great success since launching in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-22T15:02:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System","datePublished":"2022-11-22T15:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/"},"wordCount":394,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/","url":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/","name":"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg","datePublished":"2022-11-22T15:02:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221122005584\/en\/1645257\/21\/harrier_stg_cover_splash.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ChoiceSpine\u2122 Announces Line Extension of their Harrier\u2122 Stand-Alone Anterior Lumbar Interbody Fusion System"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51136"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51136\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}